Grommes, C., Dabrowska-Iwanicka, A. P., Tun, H. W., D'Angelo, C., Fuente, A. D. L., Levi, I., Nayak, L., Lavie, D., Castellino, A., Taszner, M., Ramakrishnan, P., Schenone, L., Ferreri, A. J. M., Calimeri, T., Nassi, L., Houillier, C., Schmitt, A., Choudhary, G. S., Zhao, W., Nowakowski, G. S. (2025). Analysis of genetic mutation profile and CNS pharmacokinetics in relapsed/refractory primary CNS lymphoma patients responding to novel emavusertib (IRAK4i) and BTKi combination.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2085